Avecho Biotechnology Ord Shs V.AVE

Primary Symbol: AVEFF

Healthcare

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

OTCPK:AVEFF - Post by User

Avecho Biotechnology Ord Shs > Aveda Earn Out

<< Previous

Bullboard Posts

Next >>

Post by JohnnyTSXon Oct 28, 2019 12:12pm

167 Views

Post# 30276863

Aveda Earn Out

Emailed IR last night again (been emailing them every 3 weeks or so looking for an update). Latest response not as confident as previous... "The next update from the company regarding the Aveda earnout will most likely come in the 3Q earnings call and SEC filings." Previously, the have indicated in writing that the earn out would be paid in late Q3, then they said early Q4, now it's a wait and read the filings...

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!